Product Information
ALPHAGAN P 0.15% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $39.6880 per ML under NDC 00023917715. Its NADAC has been published 663 times since Nov 28, 2013.
FDA first approved this application on Mar 16, 2001. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the brimonidine tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023917715
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA021262FDA Approved
3/16/2001
TE Code
AT
On Market Since
7/10/2001
Pharmacological Classes
Price Statistics
The NADAC for ALPHAGAN P 0.15% EYE DROPS has been published 663 times since Nov 28, 2013, and over the history we have for it it has risen 118.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.6880 per ML |
|---|---|
| All-time high | $40.0983 (May 14, 2025) |
| All-time low | $18.1585 (Nov 28, 2013) |
| 52-week high | $40.0832 |
| 52-week low | $39.6880 |
| Median price | $34.4002 |
| Average price | $32.3644 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 663 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALPHAGAN P 0.15% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ALPHAGAN P 0.15% EYE DROPS, manufactured by Allergan, Inc., is $39.6880 per ML (NDC 00023917715), effective Aug 19, 2026.
How has the price of ALPHAGAN P 0.15% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ALPHAGAN P 0.15% EYE DROPS has risen 118.6%. It has been tracked across 663 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPHAGAN P 0.15% EYE DROPS?
Since Nov 28, 2013, the NADAC for ALPHAGAN P 0.15% EYE DROPS has ranged from a low of $18.1585 (Nov 28, 2013) to a high of $40.0983 (May 14, 2025), with a median of $34.4002 per ML.
Are there cheaper alternatives to ALPHAGAN P 0.15% EYE DROPS?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.15% DRP, is $10.5824 per ML — about 73% below ALPHAGAN P 0.15% EYE DROPS.
Who manufactures ALPHAGAN P 0.15% EYE DROPS?
ALPHAGAN P 0.15% EYE DROPS (NDC 00023917715) is labeled by Allergan, Inc., and CMS classifies it as a brand product.